Myocarditis and Pericarditis After Vaccination for COVID-19

• Published in: JAMA : the journal of the American Medical Association Vol. 326; no. 12; pp. 1210 - 1212
• Main Authors: Diaz, George A, Parsons, Guilford T, Gering, Sara K, Meier, Audrey R, Hutchinson, Ian V, Robicsek, Ari
• Format: Journal Article
• Language: English
• Published: United States American Medical Association 28.09.2021
• Subjects: 2019-nCoV Vaccine mRNA-1273; Ad26COVS1; Adult; Aged; BNT162 Vaccine; Comments; Confidence Intervals; Coronaviruses; COVID-19; COVID-19 - prevention & control; COVID-19 vaccines; COVID-19 Vaccines - administration & dosage; COVID-19 Vaccines - adverse effects; Emergency medical care; Emergency medical services; Female; Health care; Heart diseases; Hospitalization - statistics & numerical data; Humans; Immunization; Incidence; Letter; Letters; Los Angeles - epidemiology; Male; Middle Aged; Montana - epidemiology; Myocarditis; Myocarditis - epidemiology; Myocarditis - etiology; Online First; Oregon - epidemiology; Pericarditis; Pericarditis - epidemiology; Pericarditis - etiology; Poisson Distribution; Research Letter; Time Factors; Vaccination; Vaccines; Washington - epidemiology; Oregon; Montana; Los Angeles; Washington

This study investigates the incidence of myocarditis and pericarditis emergency department or inpatient hospital encounters before COVID-19 vaccine availability (January 2019–January 2021) and during a COVID-19 vaccination period (February-May 2021) in a large US health care system.